A big plus for Roche today after the European Commission issued a final positive decision for its once- or twice-monthly anaemia drug Mircera for use in chronic kidney disease patients that is valid ...

US regulators have given the green light to Roche's new anaemia drug Mircera, but no launch across the Atlantic is likely for some time as the Swiss firm is embroiled in a legal dispute it is losing ...

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Mircera (methoxy polyethylene glycol-epoetin beta) for the treatment of anaemia associated with chronic kidney ...

-- First Publication of Phase III Data in the Clinical Journal of the American Society of Nephrology Results from a multi-centre renal anaemia study show that switching patients directly from frequent ...

Roche announced today that the European Commission has approved its innovative drug Mircera to treat anaemia associated with chronic kidney disease (CKD). The approval of Mircera results in a single ...

DUBLIN--(BUSINESS WIRE)--The "Drug Analysis: Mircera" drug pipelines has been added to ResearchAndMarkets.com's offering. Mircera (methoxy polyethylene glycol-epoetin beta; Roche/Vifor/Chugai) is a ...

ZURICH, May 25 (Reuters) - Roche Holding AG's potential blockbuster drug Mircera has been cleared by European authorities, who recommended allowing sales to treat anaemia linked to kidney disease.

ZURICH, May 11 (Reuters) - A U.S recommendation to restrict further a group of anaemia drugs widely used by cancer patients could hit Switzerland's Roche Holding AG , which expects an approval ...

Please provide your email address to receive an email when new articles are posted on . Among surveyed nephrologists, familiarity with Roche’s Mircera is low, but is still second highest among six ...

BOSTON U.S. District Judge William Young has ordered Amgen and Roche to submit a list of names for an expert to be appointed to their trial regarding the release of Roche’s anemia drug, Mircera, in ...

In the long battle for Amgen to prevent generic drug company Roche Holdings from bringing its anemia drug Mircera into the US market, a federal appeals court has ruled that Roche could import its drug ...

three times a week for the maintenance treatment of anaemia. The study results showed: - Minute changes in patients' haemoglobin (Hb) levels from baseline to evaluation (-0.131g/dL for MIRCERA once ...